Cannell & Spears LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1426319 NEW YORK, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$22,509,170

-$30,736,542 QoQ

Shares Held

36,099

-47.6% QoQ

Ownership

0.035%

of shares outstanding

% of Portfolio

0.42%

of 13F equity value

Holder Rank

#203

of 1,329 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cannell & Spears LLC holds $44,689,983 across 5 Biotechnology names. REGN ranks #1 (50.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	36,099	$22,509,170
2	AXSM	Axsome Therapeutics, Inc.	84,154	$20,598,374
3	VRTX	Vertex Pharmaceuticals Inc / Ma	1,966	$976,571
4	FTRE	Fortrea Holdings Inc.	31,315	$544,881
5	ALEC	Alector, Inc.	30,342	$60,987

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$22,509,170	36,099	-47.6%	Shares	Sole	2026-08-11
2026-03-31	$53,245,712	68,914	-22.9%	Shares	Sole	2026-05-15
2025-12-31	$69,001,318	89,395	+197.2%	Shares	Sole	2026-02-17
2025-09-30	$16,912,519	30,079	+13.7%	Shares	Sole	2025-11-14
2025-06-30	$13,892,025	26,461	-59.0%	Shares	Sole	2025-08-14
2025-03-31	$40,924,324	64,526	+301.9%	Shares	Sole	2025-05-14
2024-12-31	$11,436,458	16,055	+50.9%	Shares	Sole	2025-02-12
2024-09-30	$11,185,193	10,640	+0.7%	Shares	Sole	2024-11-12
2024-06-30	$11,100,978	10,562	-2.6%	Shares	Sole	2024-08-12
2024-03-31	$10,432,429	10,839	—	Shares	Sole	2024-05-10
No filing history on record for this holder in this stock.